Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Almirall, S.A., Ronda General Mitre 151, 08022, Barcelona, Spain
Lodine 600 mg SR Tablets.
| Pharmaceutical Form |
|---|
|
Lodine SR Tablets are for oral administration. Each tablet is capsular, oval shaped light grey film coated, impressed on one side with Lodine SR600 and contains etodolac 600mg in a sustained release formulation. |
Each tablet contains 600 mg of etodolac.
Excipients with known effect: Each tablet contains 109 mg lactose and 34 mg of sodium.
For the full list of excipients, see section 6.1.
| List of Excipients |
|---|
|
Hydroxypropyl methylcellulose |
Vinyl Aclar or PVdC/PVC/Aluminium foil blister packs of 2, 28 or 30 tablets.
HDPE bottle with child resistant closures of 28 or 30 tablets.
Polypropylene securitainers with polyethylene caps of 28 or 30 tablets.
Almirall, S.A., Ronda General Mitre 151, 08022, Barcelona, Spain
PL 16973/0021
02/03/2009
| Drug | Countries | |
|---|---|---|
| LODINE | France, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
